Your browser doesn't support javascript.
loading
External Validation and User Experiences of the ProPal-COPD Tool to Identify the Palliative Phase in COPD.
Broese, Johanna M C; van der Kleij, Rianne M J J; Verschuur, Els M L; Kerstjens, Huib A M; Bronkhorst, Ewald M; Chavannes, Niels H; Engels, Yvonne.
Afiliación
  • Broese JMC; Public Health & Primary Care, Leiden University Medical Center, Leiden, the Netherlands.
  • van der Kleij RMJJ; Lung Alliance Netherlands, Amersfoort, the Netherlands.
  • Verschuur EML; Public Health & Primary Care, Leiden University Medical Center, Leiden, the Netherlands.
  • Kerstjens HAM; Lung Alliance Netherlands, Amersfoort, the Netherlands.
  • Bronkhorst EM; Respiratory Medicine & Tuberculosis, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands.
  • Chavannes NH; Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Engels Y; Public Health & Primary Care, Leiden University Medical Center, Leiden, the Netherlands.
Int J Chron Obstruct Pulmon Dis ; 17: 3129-3138, 2022.
Article en En | MEDLINE | ID: mdl-36579356
ABSTRACT

Background:

Difficulty predicting prognosis is a major barrier to timely palliative care provision for patients with COPD. The ProPal-COPD tool, combining six clinical indicators and the Surprise Question (SQ), aims to predict 1-year mortality as a proxy for palliative care needs. It appeared to be a promising tool for healthcare providers to identify patients with COPD who could benefit from palliative care.

Objective:

To externally validate the ProPal-COPD tool and to assess user experiences.

Methods:

Patients admitted with an acute exacerbation COPD were recruited across 10 hospitals. Demographics, clinical characteristics and survival status were collected. Sensitivity, specificity, positive and negative predictive values of the tool using two cut-off values were calculated. Also, predictive properties of the SQ were calculated. In monitoring meetings and interviews, healthcare providers shared their experiences with the tool. Transcripts were deductively coded using six user experience domains Acceptability, Satisfaction, Credibility, Usability, User-reported adherence and Perceived impact.

Results:

A total of 523 patients with COPD were included between May 2019 and August 2020, of whom 100 (19.1%) died within 12 months. The ProPal-COPD tool had an AUC of 0.68 and a low sensitivity (55%) and moderate specificity (74%) for predicting 1-year all-cause mortality. Using a lower cut-off value, sensitivity was higher (74%), but specificity lower (46%). Sensitivity and specificity of the SQ were 56% and 73%, respectively (AUC 0.65). However, healthcare providers generally appreciated using the tool because it increased awareness of the palliative phase and provided a shared understanding of prognosis, although they considered its outcome not always correct.

Conclusion:

The accuracy of the ProPal-COPD tool to predict 1-year mortality is limited, although screening patients with its indicators increases healthcare providers' awareness of palliative care needs and encourages them to timely initiate appropriate care.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Int J Chron Obstruct Pulmon Dis Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Int J Chron Obstruct Pulmon Dis Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos